22nd Century Group Inc (XXII)

[BiotechValues]

Difference now is they have much stronger case with FDA-funded study that concluded:

“in the 30 days following the trial, smokers of very low nicotine cigarettes (XXII’s Spectrum cigarettes)reported they attempted to quit smoking at a rate double that of participants who smoked cigarettes with 15.8 mg/gram nicotine (34.7% vs. 17%)”

And these were smokers who were not planning to quit.

So getting pharma partner may be much closer now.

Incidentally- I have MBA in healthcare management and am former hospital administrator. Docs would prescribe ciggs if research backs up use and FDA approves.


And on a more personal note- I'm a former smoker. Quitting was the hardest thing I ever did in my life- and I mean that literally. it took 8 or 10 attempts, but I finally quit for good a decade ago. Anything that makes current smokers who were not planning to quit want to try quit 2X more than a control group- is a good thing.
Drugs like Chantix can be dangerous- big increase in suicide risk/etc. that ciggs would not have. FDA could easily smile on XXII.